EXHIBIT 12. STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
Eli Lilly and Company and Subsidiaries
(Dollars in millions)
(Dollars in millions)
| Years Ended December 31, | ||||||||||||||||||||
| 2006 | 2005 | 2004 | 2003 | 2002 | ||||||||||||||||
Consolidated pretax income
before cumulative effect of a
change in accounting
principle |
$ | 3,418.0 | $ | 2,717.5 | $ | 2,941.9 | $ | 3,261.7 | $ | 3,457.7 | ||||||||||
Interest |
344.8 | 245.7 | 162.9 | 121.9 | 140.0 | |||||||||||||||
Less interest capitalized
during the period |
(106.7 | ) | (140.5 | ) | (111.3 | ) | (60.9 | ) | (60.3 | ) | ||||||||||
Earnings |
$ | 3,656.1 | $ | 2,822.7 | $ | 2,993.5 | $ | 3,322.7 | $ | 3,537.4 | ||||||||||
Fixed charges |
$ | 344.8 | $ | 245.7 | $ | 162.9 | $ | 121.9 | $ | 140.0 | ||||||||||
Ratio of earnings to
fixed charges |
10.6 | 11.5 | 18.4 | 27.3 | 25.3 | |||||||||||||||